Havana, Cuba

Miguel Antonio López López


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Miguel Antonio López López: Innovator in Vaccine Adjuvants

Introduction

Miguel Antonio López López is a prominent inventor based in Havana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of innovative vaccine adjuvants. With a total of 2 patents, his work focuses on enhancing immune responses through advanced nanoparticle technology.

Latest Patents

López López's latest patents include groundbreaking inventions related to nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines. This invention describes methods for obtaining nano-particulated adjuvants formed by various synthetic variants of GM3 ganglioside. Depending on the fine structure of the fatty acid in the ceramide of the synthetic GM3, these adjuvants can specifically stimulate the humoral or cellular immune response against accompanying antigens. The invention provides immunogenic vaccine compositions that comprise peptides, polypeptides, or proteins along with the aforementioned nanoparticles, which are formed through the dispersion of hydrophobic proteins of the outer membrane complex (OMC) in solutions containing fully synthetic variants of the GM3 ganglioside.

Career Highlights

López López is affiliated with the Centro de Inmunología Molecular, where he continues to advance research in vaccine development. His innovative approach to vaccine adjuvants has the potential to significantly improve the efficacy of immunizations.

Collaborations

He has collaborated with notable colleagues, including Luis Enrique Fernández Molina and Belinda Sánchez Ramírez, contributing to a dynamic research environment focused on immunological advancements.

Conclusion

Miguel Antonio López López stands out as a key figure in the field of vaccine innovation, with his work on GM3 ganglioside nanoparticles paving the way for more effective immunization strategies. His contributions are vital for the future of vaccine development and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…